(Press-News.org) BOSTON (April 9, 2013) – Proliferative vitreoretinopathy (PVR), or the formation of scar tissue in the eye, is a serious, sight-threatening complication in people recovering from surgical repair of retinal detachment. PVR is difficult to predict, lacks effective treatment options, and substantially reduces an individual's quality of life. Each year 55,000 people are at risk for developing PVR in the United States alone.
A new study carried out by scientists from The Schepens Eye Research Institute/Massachusetts Eye and Ear and the Department of Ophthalmology, Harvard Medical School, and published on The American Journal of Pathology website and scheduled for the May 2013 print edition, suggests that Ranibizumab, an anti-VEGF-A monoclonal antibody fragment, is a potential prophylaxis for PVR.
"In this manuscript we present basic studies that have clear implications for disease pathogenesis and therapy," said senior author Andrius Kazlauskas, Ph.D, Senior Scientist and Sinon Scholar in Retinal Research, Mass. Eye and Ear/Schepens Eye Research Institute and Professor of Ophthalmology, Harvard Medical School.
Researchers found that the putative mediators of PVR pathogenesis are growth factors, which contribute to common diseases such as atherosclerosis and cancer. "Consequently, elucidating functional relationships between growth factors and resolving their contribution to pathogenesis is of wide interest because such information will substantially advance our ability to combat a broad spectrum of diseases," Dr. Kazlauskas said.
While investigating the functional relationships between growth factors known to promote pervasive human diseases, researchers discovered that Ranibizumab reduced the bioactivity of vitreous from patients and experimental animals with PVR, and protected rabbits from developing this disease.
These pre-clinical findings suggest that one of the clinically approved approaches to neutralize VEGF-A constitutes a novel prophylactic for an incurable, blinding disease.
"Our discoveries also raise the provocative idea that anti-VEGF-based therapies may be effective for managing more than the angiogenesis- and vascular-permeability-driven pathological conditions," Dr. Kazlauskas continues.
###
This study was funded by the NIH/National Eye Institute (EY022970), the Massachusetts Lions Foundation, the Department of Defense (WB1XWH-10-1-0392) and Canadian Institutes of Health Research (CIHR).
The full list of collaborators is available in the manuscript.
About Massachusetts Eye and Ear
Mass. Eye and Ear clinicians and scientists are driven by a mission to find cures for blindness, deafness and diseases of the head and neck. After uniting with Schepens Eye Research Institute in 2011, Mass. Eye and Ear in Boston became the world's largest vision and hearing research center, offering hope and healing to patients everywhere through discovery and innovation. Mass. Eye and Ear is a Harvard Medical School teaching hospital and trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Internationally acclaimed since its founding in 1824, Mass. Eye and Ear employs full-time, board-certified physicians who offer high-quality and affordable specialty care that ranges from the routine to the very complex. U.S. News & World Report's "Best Hospitals Survey" has consistently ranked the Mass. Eye and Ear Departments of Otolaryngology and Ophthalmology as top five in the nation. Mass. Eye and Ear is home to the Ocular Genomics Institute which aims to translate the promise of personalized genomic medicine into clinical care. END
Ranibizumab may prevent retinal detachment side effect
Research online, to be published in the May 2013 issue of American Journal of Pathology
2013-04-09
ELSE PRESS RELEASES FROM THIS DATE:
AACR news: Misregulated genes common to tobacco-related cancers offer potential new prognostic tool
2013-04-09
Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes.
"We ultimately envision this as a prognostic tool to predict survival rates for people with tobacco related cancers. Recognizing patients with high expression of these ...
AACR news: K9 osteosarcoma samples identify drivers of metastasis in pediatric bone cancer
2013-04-09
Human osteosarcoma samples are hard to come by, making the disease difficult to study. However, K9 bone cancer is genetically indistinguishable from the human form of the disease, and over 10,000 canine patients develop the disease every year. Research from the University of Colorado Cancer Center and the Colorado State University Flint Animal Cancer Center presented at the AACR Annual Meeting 2013 used easily available K9 osteosarcoma samples to discover a novel protein that governs metastasis and chemoresistance in pediatric osteosarcoma.
"We have a pediatric osteosarcoma ...
AACR news: New target plus new drug equals death of melanoma cells
2013-04-09
Collaborative research presented by the University of Colorado Cancer Center, the University of North Carolina at Chapel Hill, Harvard Medical School and the University of Pittsburgh, at the American Association for Cancer Research (AACR) Annual Conference, shows that the protein receptor Mer is overexpressed in melanoma and that the investigational drug UNC1062 blocks Mer survival signaling in these cells, killing them.
"It's exciting in that Mer receptor expression correlates so perfectly with disease progression. It's tiered – you see a bump in expression as you transition ...
AACR news: Rigosertib Phase 1 results lead to disease-focused Phase 2 development
2013-04-09
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This is the first trial in which orally administered Rigosertib, a dual kinase inhibitor, was studied in solid tumors. Intravenously rigosertib is already in phase 3 clinical trials for myelodysplastic syndrome and pancreatic cancer and oral rigosertib is being studied in a pair of Phase II trials in lower-risk transfusion dependent MDS patients. The drug ...
AACR news: Little molecule makes big difference in bladder cancer metastasis
2013-04-09
In order to kill, bladder cancer must metastasize, most commonly to the lung – what are the differences between bladder cancers that do and do not make this deadly transition? Research presented by the Director of the University of Colorado Cancer Center at the AACR Annual Meeting 2013 shows that one big difference is a little molecule known as hsa-miR-146a.
Messenger RNA or mRNA carries gene blueprints to sites where the plans are read and made into proteins, and to a large degree microRNA or miRNA tells mRNA what to do. Theodorescu's work shows that in 256 samples of ...
AACR news: Six2 homeoprotein allows breast cancer cells to detach and metastasize
2013-04-09
In results presented at the AACR Annual Meeting 2013, researchers from the University of Colorado Cancer Center show that the Six2 homeoprotein, while not involved in primary tumor growth, allows cells to detach from substrate and survive their transition through the bloodstream to faraway sites of metastasis.
"Here we show for the first time that Six2 causes breast cancer progression. It's this metastasis, especially to the lung, that can eventually be deadly and so perhaps even more so than affecting the size of the primary tumor, we are especially excited to present ...
1-2 punch could be key in treating blindness
2013-04-09
EAST LANSING, Mich. — Researchers have discovered that using two kinds of therapy in tandem may be a knockout combo against inherited disorders that cause blindness. While their study focused on man's best friend, the treatment could help restore vision in people, too.
Published in the journal Molecular Therapy, the study builds on earlier work by Michigan State University veterinary ophthalmologist András Komáromy and colleagues. In 2010, they restored day vision in dogs suffering from achromatopsia, an inherited form of total color blindness, by replacing the mutant ...
High pressure gold nanocrystal structure revealed
2013-04-09
A major breakthrough in measuring the structure of nanomaterials under extremely high pressure has been made by researchers at the London Centre for Nanotechnology (LCN).
Described in Nature Communications, the study used new advances in x-ray diffraction to image the changes in morphology of gold nanocrystals under pressures of up to 6.5 gigapascals.
Under high pressures, imaging methods such as electron or atomic force microscopy are not viable, making x-ray diffraction imaging the only option. However, until recently, focusing an image created with this method ...
Nanotechnology imaging breakthrough
2013-04-09
Washington, D.C.— A team of researchers has made a major breakthrough in measuring the structure of nanomaterials under extremely high pressures. For the first time, they developed a way to get around the severe distortions of high-energy X-ray beams that are used to image the structure of a gold nanocrystal. The technique, described in April 9, 2013, issue of Nature Communications, could lead to advancements of new nanomaterials created under high pressures and a greater understanding of what is happening in planetary interiors.
Lead author of the study, Wenge Yang ...
Dedicated cleaning staff shown to reduce C. difficile contamination in hospital rooms
2013-04-09
With rates and deaths associated with Clostridium difficile (C. difficile) at historically high levels, many hospitals have taken extra steps to reduce these infections. New research finds that a dedicated daily cleaning crew who adequately clean and disinfect rooms contaminated by C. difficile using a standardized process can be more effective than other disinfection interventions. The study is published in the May issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), in a special topic issue focused ...
LAST 30 PRESS RELEASES:
Research alert: Bioinformatics uncovers regenerative therapy for spinal cord injury
Sustainable chemistry with the help of Artificial Intelligence
Quantum jam sessions teach quantum and jamming
Health care professionals sponsored for H-1B visas in the US
Study shows increase of H1-B visa fees will most impact rural and high-poverty counties
How age affects vaccine responses and how to make them better
MAGIC: AI-assisted laser tag illuminates cancer origins
Major milestone achieved in capturing ribosome assembly
International research team decodes the pangenome of oats
A doorstop for the brain’s electrical gates
Tiny 3D printer reconstructs tissues during vocal cord surgery
New genetic marker found to predict severe gout drug reactions in US patients
Schizophrenia, bipolar, or major depressive disorder and postacute sequelae of COVID-19
Fruit flies offer new insights into how human Alzheimer’s Disease risk genes affect the brain
University of Phoenix College of Doctoral Studies releases white paper on mentoring programs to strengthen worker autonomy and competitive edge
International scientists issue State of the Climate Report, highlight mitigation strategies
“State of the climate” 2025: Earth’s vital signs worsen, science shows options for livable future
New nanomedicine wipes out leukemia in animal study
National TRAP Program targets ghostly issue with second round of coastal clean up funding
Six scientists receive AFAR grants for junior faculty
Climate report: Earth on dangerous path but rapid action can avert the worst outcomes
American Pediatric Society announces Bruce D. Gelb, MD, as recipient of its prestigious 2026 APS John Howland Award
Friendships can ease loneliness for dementia caregivers
Researchers pose five guiding questions to improve the use of artificial intelligence in physicians’ clinical decision-making
Global call to “Help the Kelp” with US $14 billion conservation target
Artificial tongue uses milk to determine heat level in spicy foods
IU Kelley Futurecast: AI and energy infrastructure may buoy US economy in 2026
The biggest threats to maintaining fat bike trails: climate change and volunteer burnout
AI models for drug design fail in physics
Practice pattern of aerosol drug therapy in acute respiratory distress syndrome patients: An aero-in-ICU study
[Press-News.org] Ranibizumab may prevent retinal detachment side effectResearch online, to be published in the May 2013 issue of American Journal of Pathology